Z Gastroenterol 2021; 59(08): e230
DOI: 10.1055/s-0041-1733672
ACLF und TIPS
Freitag, 17. September 2021, 13:30-14:50 Uhr, Saal 4
Leber und Galle

Improvement of quality of life after TIPS insertion

SA Keimburg
1   Uniklinik Essen, Gastroenterologie und Hepatologie, Essen, Deutschland
,
J Theysohn
2   Uniklinik Essen, Institute für Diagnostische und Interventionelle Radiologie und Neuroradiologie, Essen, Deutschland
,
M Buechter
1   Uniklinik Essen, Gastroenterologie und Hepatologie, Essen, Deutschland
,
J Rashidi
1   Uniklinik Essen, Gastroenterologie und Hepatologie, Essen, Deutschland
,
A Wetter
2   Uniklinik Essen, Institute für Diagnostische und Interventionelle Radiologie und Neuroradiologie, Essen, Deutschland
,
C Lange
1   Uniklinik Essen, Gastroenterologie und Hepatologie, Essen, Deutschland
,
H Wedemeyer
1   Uniklinik Essen, Gastroenterologie und Hepatologie, Essen, Deutschland
3   Medizinische Hochschule Hannover, Gastroenterologie, Hepatologie und Endokrinologie, Hannover, Deutschland
,
Markova AA
1   Uniklinik Essen, Gastroenterologie und Hepatologie, Essen, Deutschland
› Author Affiliations
 

Background and aims Hydropic decompensation and/or bleeding episodes in liver cirrhosis lead to a significant reduction in the quality of life (QOL). Transjugular intrahepatic portosystemic shunt (TIPS) improves clinical outcome. We aimed to investigate the impact of TIPS insertion on QOL in a homogeneous single-center cohort.

Methods Liver cirrhosis patients who underwent TIPS insertion between January 2018 until December 2020 were studied. Patients who died, got transplanted or were lost to follow-up during the first three months after TIPS intervention were excluded. The SF-36 questionnaire was filled prior to-, 3- and 12- months post-intervention in 77 patients.

Results The majority of patients was male (63 %), median age was 57 years. Baseline Child-Turcotte-Pugh (CTP) stage was A in 16 %, B in 72 % and C in 12 %. Main indication for TIPS was refractory ascites (81 %). Liver transplant-free survival was 90 % and 73 % at months 3 and 12, respectively. At baseline, seven out of eight SF-36 scales were lower than the population mean of 50 %. After TIPS intervention, a significant increase in mean QOL (more than 10 points) was observed in all dimensions [Fig. 1]. The physical (PCS) and mental (MCS) summary measures improved over the time accordingly (mean PCS 27 vs 40 % and mean MCS 39 vs 46 % prior-to (BL) and 12-months (M12) after TIPS). Overall, the summary score showed no improvement or a worsening only in 5 and in 10 patients for PCS and MCS accordingly. The most significant improvement in physical scores was noted in Child-Pugh B patients, while mental scores showed a more pronounced increase in Child-Pugh C patients.

Conclusion As an established therapy for portal hypertension complications, TIPS insertion leads not only to an increased liver transplant-free survival but also to an improvement in all scales of QOL. However, physical scores showed only a minor improvement in advanced stage of liver cirrhosis.

Zoom Image
Abb 1. SF-36 scales for BL and M12


Publication History

Article published online:
07 September 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany